| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MYBL2_0003000 | Exon-Exon | chr20:42331130-42345122 | chr20:43702490-43716482 | 1547 nt | 0.5921 |
| hsa_MYBL2_0003400 | Exon-Exon | chr20:42333859-42345122 | chr20:43705219-43716482 | 1133 nt | 0.5869 |
| hsa_MYBL2_0003500 | Exon-Exon | chr20:42338603-42345122 | chr20:43709963-43716482 | 993 nt | 0.5891 |
| hsa_MYBL2_0003800 | Exon-Exon | chr20:42341642-42345122 | chr20:43713002-43716482 | 779 nt | 0.5892 |
| hsa_MYBL2_0003900 | Exon-Exon | chr20:42343774-42345122 | chr20:43715134-43716482 | 674 nt | 0.5979 |
| hsa_chr20_0166100 | Intergenic-Intergenic | chr20:42297836-42298363 | chr20:43669196-43669723 | 528 nt | 0.5568 |
| hsa_MYBL2_0000300 | Intron-Exon-Intron | chr20:42301611-42302539 | chr20:43672971-43673899 | 929 nt | 0.4919 |
| hsa_MYBL2_0000900 | Exon-Exon | chr20:42302446-42311526 | chr20:43673806-43682886 | 94 nt | 0.5426 |
| hsa_MYBL2_0001000 | Exon-Exon | chr20:42302446-42320959 | chr20:43673806-43692319 | 221 nt | 0.5973 |
| hsa_MYBL2_0000700 | Exon-Exon | chr20:42302446-42328684 | chr20:43673806-43700044 | 931 nt | 0.5725 |
A study in human acute myeloid leukemia (AML) demonstrated that the circMYBL2 is crucial for FLT3-dependent leukemia progression, where it interacts with PTBP1 to increase mutant FLT3 kinase protein levels [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A study in humans demonstrated that the circMYBL2 is a circular RNA with expression restricted to venous blood samples, serving as a specific biomarker for body fluid identification [Yu et al. DOI:10.1016/j.fsigen.2025.103416].